New trial results question standard treatment plan for rheumatoid arthritis
In a clinical trial of patients with rheumatoid arthritis, treatment with a drug called upadacitinib provided greater benefits than methotrexate, the most commonly used initial therapy for rheumatoid arthritis.
Jul 8, 2020
0
3